Embecta Corp. Declares Quarterly Cash Dividend of $0.15 per Share

Embecta Corp. declared a $0.15 quarterly dividend payable on March 17, 2026, to stockholders of record by February 27, 2026.

Quiver AI Summary

Embecta Corp. has announced a quarterly cash dividend of $0.15 per share for its common stock, which will be payable on March 17, 2026, to shareholders recorded as of February 27, 2026. The company, which is focused on advancing its legacy in insulin delivery and expanding into a broader range of medical supplies, employs around 2,000 people worldwide. For further details, interested parties can visit embecta.com or follow the company's social media channels.

Potential Positives

The declaration of a quarterly cash dividend demonstrates the company’s commitment to delivering value to its shareholders.
This move indicates financial stability and confidence in the company's ongoing operations and future prospects.
The timing of the dividend payment aligns with standard corporate practices, enhancing investor trust and maintaining positive relations with stockholders.
Embecta’s efforts to transition into a broad-based medical supplies company signal growth potential and an expanded market presence.

Potential Negatives

The decision to declare a dividend of $0.15 may signal to investors that the company is prioritizing short-term returns over long-term growth and investment, which could raise concerns about its financial health and future prospects.
The low dividend amount may be perceived as a lack of confidence in generating higher profits, potentially impacting investor sentiment and stock performance.
The press release does not provide any updates on the company's financial performance or strategic initiatives, leaving investors with limited information about the company's direction and stability.

FAQ

What is the latest dividend declared by Embecta Corp?

Embecta Corp has declared a quarterly cash dividend of $0.15 per share.

When will the dividend payment be made?

The dividend is payable on March 17, 2026.

What is the record date for the dividend?

The record date for the dividend is February 27, 2026.

How can I find more information about Embecta?

More information about Embecta can be found on their website embecta.com or through their social media channels.

What does Embecta focus on in its business?

Embecta focuses on insulin delivery and aims to expand into a broad-based medical supplies company.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$EMBC Revenue

$EMBC had revenues of $264M in Q4 2025. This is a decrease of -7.72% from the same period in the prior year.

You can track EMBC financials on Quiver Quantitative's EMBC stock page.

$EMBC Hedge Fund Activity

We have seen 129 institutional investors add shares of $EMBC stock to their portfolio, and 171 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

VANGUARD GROUP INC removed 846,891 shares (-15.5%) from their portfolio in Q4 2025, for an estimated $10,061,065
JEFFERIES FINANCIAL GROUP INC. added 542,162 shares (+40.4%) to their portfolio in Q3 2025, for an estimated $7,649,905
SG AMERICAS SECURITIES, LLC added 435,842 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,177,802
UBS GROUP AG added 421,254 shares (+200.8%) to their portfolio in Q4 2025, for an estimated $5,004,497
MILLENNIUM MANAGEMENT LLC removed 388,531 shares (-21.3%) from their portfolio in Q3 2025, for an estimated $5,482,172
QUBE RESEARCH & TECHNOLOGIES LTD removed 362,935 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,121,012
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 312,857 shares (-15.7%) from their portfolio in Q3 2025, for an estimated $4,414,412

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$EMBC Analyst Ratings

Wall Street analysts have issued reports on $EMBC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 09/05/2025

To track analyst ratings and price targets for $EMBC, check out Quiver Quantitative's $EMBC forecast page.

Full Release

PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on March 17, 2026 to stockholders of record at the close of business on February 27, 2026.

About embecta

embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn , Facebook , and Instagram .

Contacts:

Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations	Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR